Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00617019
Other study ID # 248.619
Secondary ID DOMINION
Status Completed
Phase N/A
First received February 5, 2008
Last updated November 11, 2013
Start date September 2006

Study information

Verified date November 2013
Source Boehringer Ingelheim
Contact n/a
Is FDA regulated No
Health authority Canada:United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.


Recruitment information / eligibility

Status Completed
Enrollment 3234
Est. completion date
Est. primary completion date January 2008
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 75 Years
Eligibility Inclusion Criteria:

Observation Criteria:

Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample.

Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator.

Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation.

Exclusion Criteria:

Study Design

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Canada 248.619.02011 University of Calgary Calgary Alberta
Canada 248.619.02010 The Glenrose Rehab. Hospital Edmonton Alberta
Canada 248.619.02019 Dr. David King Halifax Nova Scotia
Canada 248.619.02013 Kitchener Ontario
Canada 248.619.02018 London HSC - University Hospital London Ontario
Canada 248.619.02001 Centre for Movement Discorder Markham Ontario
Canada 248.619.02003 Unite des Troubles du Mouvement Montreal Quebec
Canada 248.619.02008 Ottawa Civic Hospital Ottawa Ontario
Canada 248.619.02002 Memory and Motor Skills Disorders Clinic Quebec
Canada 248.619.02017 Royal University Hospital Saskatoon Saskatchewan
Canada 248.619.02005 Health Sciences Centre St. John's Newfoundland and Labrador
Canada 248.619.02016 The Toronto Western Hospital Toronto Ontario
Canada 248.619.02009 Movement Disorder Clinic Winnipeg Manitoba
United States 248.619.01030 Parkinson's Disease and Movement Disorders Center Albany New York
United States 248.619.01004 Lehigh Valley Hospital Allentown Pennsylvania
United States 248.619.01035 Emory University Atlanta Georgia
United States 248.619.01006 Medical College of Georgia Augusta Georgia
United States 248.619.01015 John Hopkins Hospital Baltimore Maryland
United States 248.619.01020 Parkinson's Disease and Movement Disorders of Boca Raton Boca Raton Florida
United States 248.619.01014 Northwestern University Chicago Illinois
United States 248.619.01028 The Cleveland Clinic Foundation Cleveland Ohio
United States 248.619.01036 Parkinson's Disease and Mov. Disorders Center of Long Island Commack New York
United States 248.619.01032 Neurology Spclst of Dallas, PA Dallas Texas
United States 248.619.01027 Associated Neurologists, P.C. Danbury Connecticut
United States 248.619.01003 Duke University Medical Center Durham North Carolina
United States 248.619.01021 Boehringer Ingelheim Investigational Site Englewood Colorado
United States 248.619.01018 Margolin Brain Institute Fresno California
United States 248.619.01009 University of Florida Gainesville Florida
United States 248.619.01034 Neurological Physicians of Arizona Gilbert Arizona
United States 248.619.01002 Baylor College of Medicine Houston Texas
United States 248.619.01001 The University of Kansas Medical Center Kansas City Kansas
United States 248.619.01022 University of Minnesota Minneapolis Minnesota
United States 248.619.01033 Vanderbilt University Medical Center Nashville Tennessee
United States 248.619.01013 Molecular NeuroImaging New Haven Connecticut
United States 248.619.01017 Weill Cornell medical College New York New York
United States 248.619.01031 Pacific Neuroscience Medical Group, Inc. Oxnard California
United States 248.619.01010 Parkinson's Disease research, Education and Clinical Center Philadelphia Pennsylvania
United States 248.619.01011 University of Pennsylvania Philadelphia Pennsylvania
United States 248.619.01024 Thomas Jefferson Hospital Philadelphia Pennsylvania
United States 248.619.01008 Robert Wood Johnson Medical School Piscataway New Jersey
United States 248.619.01019 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania
United States 248.619.01026 Neurology/Southeast Parkinson's Disease Richmond Virginia
United States 248.619.01016 San Francisco VA PD Research, Education, & Clinical Center San Francisco California
United States 248.619.01007 Mayo Clinic - Scottsdale Scottsdale Arizona
United States 248.619.01029 Clinical Neuroscience Center Southfield Michigan
United States 248.619.01025 Sun Health Research Institute Sun City Arizona
United States 248.619.01023 The Parkinson's Institute Sunnyvale California
United States 248.619.01012 Parkinson's Disease and Movement Disorders Center Upland Pennsylvania
United States 248.619.01005 NeuroHealth Warwick Rhode Island

Sponsors (1)

Lead Sponsor Collaborator
Boehringer Ingelheim

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire 6 months No
Secondary The occurrence of a past (since onset of PD) ICD 6 months No
Secondary Demographic and medical history measures up to 14 days after Visit 1 No
Secondary Scores on psychiatric/neuropsychological instruments/tests up to 14 days after Visit 1 No
See also
  Status Clinical Trial Phase
Completed NCT05415774 - Combined Deep Brain Stimulation in Parkinson's Disease N/A
Recruiting NCT04691661 - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease Phase 2
Active, not recruiting NCT05754086 - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed NCT04045925 - Feasibility Study of the Taïso Practice in Parkinson's Disease N/A
Recruiting NCT04194762 - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation N/A
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05830253 - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT06139965 - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed NCT04580849 - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease N/A
Completed NCT03980418 - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam N/A
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Completed NCT04942392 - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic N/A
Terminated NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT04997642 - Parkinson's Disease and Movement Disorders Clinical Database
Completed NCT04117737 - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson N/A
Recruiting NCT03618901 - Rock Steady Boxing vs. Sensory Attention Focused Exercise N/A

External Links